The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe ...

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Find insight on AstraZeneca, Eli Lilly, Siemens Healthineers and more in the latest Market Talks covering Health Care.

Shares in French cosmetics giant L'Oreal fell by more than 4% in early trade on Friday after the company posted its slowest ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

CEO Jeff Tangney reported $169 million in revenue for Q3 2025, marking a 25% year-over-year growth and a 10% beat from the high end of guidance. Adjusted EBITDA margin reached 61%, with $102 million ...

Bausch Health Companies Inc.’s BHC share price has dipped by 10.90%, which has investors questioning if this is right time to buy.

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...

It was manufactured by a well-known pharmaceutical company and may be used to treat a specific group of patients managing hypertension.

A new method has been created for determining N-nitrosamines (NAs) in pharmaceutical preparations using liquid chromatography ...